[Pain in kidney disease].
There are little data concerning the prevalence of pain and its intensity in the population suffering from kidney diseases. However, according to number of pathologies with a kidney impact, the sequellae of the kidney disease itself and the technology in this area, there is a risk for a high prevalence rate of either acute and/or chronic pain. This can be responsible for some degree of psychologic disturbances as a major impact on the quality of life. Pain management must be a challenge in this field as it may interfere with the kidney disease.
Martinez
V
V
Centre d'évaluation et de traitement de la douleur, Hôpital Ambroise Paré, Boulogne-Billancourt.
Tassain
V
V
Brasseur
L
L
D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D006801:Humans; D007674:Kidney Diseases / Q000150:complications*; D010146:Pain / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D010147:Pain Measurement
D018712:Analgesics, Non-Narcotic; D000701:Analgesics, Opioid; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000927:Anticonvulsants; D000928:Antidepressive Agents